These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 30374525)

  • 1. Atypical parkinsonism of progressive supranuclear palsy-parkinsonism (PSP-P) phenotype with rare variants in FBXO7 and VPS35 genes associated with Lewy body pathology.
    Menšíková K; Tučková L; Kolařiková K; Bartoníková T; Vodička R; Ehrmann J; Vrtěl R; Procházka M; Kaňovský P; Kovacs GG
    Acta Neuropathol; 2019 Jan; 137(1):171-173. PubMed ID: 30374525
    [No Abstract]   [Full Text] [Related]  

  • 2. Familial atypical parkinsonism with rare variant in VPS35 and FBXO7 genes: A case report.
    Bartonikova T; Mensikova K; Mikulicova L; Vodicka R; Vrtel R; Godava M; Vastik M; Kaiserova M; Otruba P; Dolinova I; Nevrly M; Kanovsky P
    Medicine (Baltimore); 2016 Nov; 95(46):e5398. PubMed ID: 27861377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progressive supranuclear palsy--parkinsonian disorder with tau pathology.
    Kowalska A; Jamrozik Z; Kwieciński H
    Folia Neuropathol; 2004; 42(2):119-23. PubMed ID: 15266787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progressive supranuclear palsy; an unusual form of parkinsonism].
    Donker Kaat L; Boon AJ; Heutink P; van Swieten JC
    Ned Tijdschr Geneeskd; 2004 Mar; 148(11):519-23. PubMed ID: 15054950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial aggregation of parkinsonism in progressive supranuclear palsy.
    Donker Kaat L; Boon AJ; Azmani A; Kamphorst W; Breteler MM; Anar B; Heutink P; van Swieten JC
    Neurology; 2009 Jul; 73(2):98-105. PubMed ID: 19458322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyramidal system involvement in progressive supranuclear palsy - a clinicopathological correlation.
    Stejskalova Z; Rohan Z; Rusina R; Tesar A; Kukal J; Kovacs GG; Bartos A; Matej R
    BMC Neurol; 2019 Mar; 19(1):42. PubMed ID: 30894142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic susceptibility variants in parkinsonism.
    Soto-Ortolaza AI; Ross OA
    Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(0 1):S7-11. PubMed ID: 26414118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. "Atypical" atypical parkinsonism: Critical appraisal of a cohort.
    Hirschbichler ST; Erro R; Ganos C; Stamelou M; Batla A; Balint B; Bhatia KP
    Parkinsonism Relat Disord; 2017 Apr; 37():36-42. PubMed ID: 28236526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical parkinsonism in Guadeloupe: a common risk factor for two closely related phenotypes?
    Lannuzel A; Höglinger GU; Verhaeghe S; Gire L; Belson S; Escobar-Khondiker M; Poullain P; Oertel WH; Hirsch EC; Dubois B; Ruberg M
    Brain; 2007 Mar; 130(Pt 3):816-27. PubMed ID: 17303592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Autopsy Case of Progressive Supranuclear Palsy With Incidental ATXN2 Expansion.
    Kim A; Park SH; Jeon B
    JAMA Neurol; 2018 Aug; 75(8):1025-1027. PubMed ID: 29801076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paraneoplastic syndrome mimicking progressive supranuclear palsy.
    Dash D; Choudhary R; Ramanujam B; Vasantha PM; Tripathi M
    J Clin Neurosci; 2016 Oct; 32():162-3. PubMed ID: 27318371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Progressive supranuclear palsy as a disease phenotype caused by the S305S tau gene mutation.
    Wszolek ZK; Tsuboi Y; Uitti RJ; Reed L; Hutton ML; Dickson DW
    Brain; 2001 Aug; 124(Pt 8):1666-70. PubMed ID: 11459757
    [No Abstract]   [Full Text] [Related]  

  • 13. What features improve the accuracy of the clinical diagnosis of progressive supranuclear palsy-parkinsonism (PSP-P)?
    Williams DR; Lees AJ
    Mov Disord; 2010 Feb; 25(3):357-62. PubMed ID: 20108379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetics of parkinsonism.
    Gwinn-Hardy K
    Mov Disord; 2002 Jul; 17(4):645-56. PubMed ID: 12210852
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiation of progressive supranuclear palsy: clinical, imaging and laboratory tools.
    Liscic RM; Srulijes K; Gröger A; Maetzler W; Berg D
    Acta Neurol Scand; 2013 May; 127(5):362-70. PubMed ID: 23406296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parkinsonism and frontotemporal dementia: the clinical overlap.
    Espay AJ; Litvan I
    J Mol Neurosci; 2011 Nov; 45(3):343-9. PubMed ID: 21892619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lewy bodies in progressive supranuclear palsy represent an independent disease process.
    Uchikado H; DelleDonne A; Ahmed Z; Dickson DW
    J Neuropathol Exp Neurol; 2006 Apr; 65(4):387-95. PubMed ID: 16691119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetics Underlying Atypical Parkinsonism and Related Neurodegenerative Disorders.
    Scholz SW; Bras J
    Int J Mol Sci; 2015 Oct; 16(10):24629-55. PubMed ID: 26501269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Steele-Richardson-Olszewski syndrome in a patient with a single C212Y mutation in the parkin protein.
    Morales B; Martínez A; Gonzalo I; Vidal L; Ros R; Gomez-Tortosa E; Rabano A; Ampuero I; Sánchez M; Hoenicka J; García De Yébenes J
    Mov Disord; 2002 Nov; 17(6):1374-80. PubMed ID: 12465088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic criteria of parkinsonian syndromes].
    Tison F
    Rev Neurol (Paris); 2003 May; 159(5 Pt 2):3S19-23. PubMed ID: 12773884
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.